view in publisher's site

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30. doi: 10.1053/j.gastro.2011.10.001. Epub 2011 Oct 14.Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.Molodecky NA1, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG.Author information1Department of Medicine, University of Calgary, Calgary, Alberta, Canada.AbstractBACKGROUND & AIMS: We conducted a systematic review to determine changes in the worldwide incidence and prevalence of ulcerative colitis (UC) and Crohn's disease (CD) in different regions and with time.METHODS: We performed a systematic literature search of MEDLINE (1950-2010; 8103 citations) and EMBASE (1980-2010; 4975 citations) to identify studies that were population based, included data that could be used to calculate incidence and prevalence, and reported separate data on UC and/or CD in full manuscripts (n = 260). We evaluated data from 167 studies from Europe (1930-2008), 52 studies from Asia and the Middle East (1950-2008), and 27 studies from North America (1920-2004). Maps were used to present worldwide differences in the incidence and prevalence of inflammatory bowel diseases (IBDs); time trends were determined using joinpoint regression.RESULTS: The highest annual incidence of UC was 24.3 per 100,000 person-years in Europe, 6.3 per 100,000 person-years in Asia and the Middle East, and 19.2 per 100,000 person-years in North America. The highest annual incidence of CD was 12.7 per 100,000 person-years in Europe, 5.0 person-years in Asia and the Middle East, and 20.2 per 100,000 person-years in North America. The highest reported prevalence values for IBD were in Europe (UC, 505 per 100,000 persons; CD, 322 per 100,000 persons) and North America (UC, 249 per 100,000 persons; CD, 319 per 100,000 persons). In time-trend analyses, 75% of CD studies and 60% of UC studies had an increasing incidence of statistical significance (P < .05).CONCLUSIONS: Although there are few epidemiologic data from developing countries, the incidence and prevalence of IBD are increasing with time and in different regions around the world, indicating its emergence as a global disease.Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.PMID: 22001864 DOI: 10.1053/j.gastro.2011.10.001 [Indexed for MEDLINE] SharePublication types, MeSH terms, Grant supportPublication typesResearch Support, Non-U.S. Gov'tReviewSystematic ReviewMeSH termsAsia/epidemiologyColitis, Ulcerative/epidemiology*Crohn Disease/epidemiology*Developing Countries/statistics & numerical dataEurope/epidemiologyGlobal HealthHumansIncidenceMiddle East/epidemiologyNorth America/epidemiologyPrevalenceRegression AnalysisResidence CharacteristicsTime FactorsGrant supportCanadian Institutes of Health Research/CanadaLinkOut - more resourcesFull Text SourcesElsevier ScienceClinicalKeyOther Literature SourcesSee the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. - Faculty of 1000Cited by Patents in - The LensMedicalClinicalTrials.govCrohn's Disease - MedlinePlus Health InformationUlcerative Colitis - MedlinePlus Health Information

افزایش بروز و شیوع بیماری‌های التهابی با گذشت زمان، براساس مرور سیستماتیک

ترجمه شده با

پر ارجاع‌ترین مقالات مرتبط:

  • مقاله Gastroenterology
  • ترجمه مقاله Gastroenterology
  • مقاله گوارش
  • ترجمه مقاله گوارش
سفارش ترجمه مقاله و کتاب - شروع کنید

با استفاده از افزونه دانلود فایرفاکس چکیده مقالات به صورت خودکار تشخیص داده شده و دکمه دانلود فری‌پیپر در صفحه چکیده نمایش داده می شود.